Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F146 - Chronic Urticaria and Angioedema: What's New in Pathogenesis and Treatment

Monday, February 19; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Discuss the pathophysiology of CIU
  • Utilize Antihistamines for CIU
  • Design a treatment plan for CIU patients resistant to antihistamines


This session will provide the attendee with up to date information regarding the pathophysiology of chronic idiopathic urticaria (CIU) and idiopathic angioedema as well as describe the appropriate use of antihistamines for these disorders. In addition, the attendee will learn about other treatment approaches for CIU and angioedema patients resistant to antihistamines.


  • Baker, Diane Romayne, MD: Aimmune Therapeutics, Inc. – I(Grants/Research Funding); Circassia Limited – O(Grants/Research Funding); CSL Behring – O(Grants/Research Funding); GlaxoSmithKline – O(Grants/Research Funding); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Regeneron – I(Grants/Research Funding); sanofi-aventis – O(Grants/Research Funding); Stallergenes Greer Inc. – O(Grants/Research Funding); Teva Pharmaceuticals USA – O(Grants/Research Funding);
  • Garritson, Emily Margaret, MD: no financial relationships exist with commercial interests.
  • Leslie, Tabi Anika, MBBS: no financial relationships exist with commercial interests.
  • Tharp, Michael D., MD: AbbVie – I(Grants/Research Funding); Actelion – I(Grants/Research Funding); BestDoctors – C(Fees); Boehringer Ingelheim – I(Grants/Research Funding); Corrona, Inc. – I(Grants/Research Funding); Cutanea Life Sciences – I(Grants/Research Funding); Elorac, Inc. – I(Grants/Research Funding); Galderma USA – I(Grants/Research Funding); GlaxoSmithKline – I(Grants/Research Funding); Kyowa Hakko USA – I(Grants/Research Funding); Leo Pharma Inc – I(Grants/Research Funding); Medical Information Network – F(S); Solgenix, Inc. – I(Grants/Research Funding); Unilever Home & Personal Care USA – A(Grants/Research Funding);
Monday, February 19
3:30 PM
Dr. Tharp / Introduction
3:35 PM
Dr. Leslie / Pathophysiology of Urticaria and Angioedema
3:55 PM
Dr. Baker / Workup for CIU and angioedema
4:10 PM
Dr. Leslie / Use of antihistamines for CIU/angiodedema
4:25 PM
Dr. Baker / Omalizumab for CIU
4:40 PM
Dr. Garritson / Use of dapsone for CIU
5:05 PM
Dr. Tharp / Other treatments for CIU
5:20 PM
All faculty / Questions
Event Details
  • Date
    Monday, February 19
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 29D
  • CME Credits
  • Type
  • Michael D. Tharp, MD, FAAD
  • Diane Romayne Baker, MD, FAAD
  • Emily Margaret Garritson, MD, FAAD
  • Tabi Anika Leslie, MBBS